AI Article Synopsis
- The study investigates the inconsistent effects of aloe vera on metabolic health, focusing on its influence on glucose levels and other biomarkers.
- Four systematic reviews were examined, revealing significant reductions in fasting blood glucose (FBG) and HbA1c in individuals with Type 2 Diabetes Mellitus (T2DM) and pre-diabetes.
- The findings suggest moderate to high-quality evidence supporting aloe vera's beneficial effects for these conditions.
Article Abstract
Background And Aims: The effects of aloe vera are inconsistent and unclear. The aim of this study is to analyze the effects of aloe vera in metabolic profiles.
Methods: An electronic search of systematic reviews (SRs) was performed in seven databases up to June 2021.
Results: Four SRs met the eligibility criteria. In T2DM, SMD for FBG = -5.61 (p < 0.001). For HbA1c, MD = -0.95 (p = 0.02). In pre-diabetes, SMD for FBG = -1.41 (p = 0.02). For HbA1c, MD = -0.31 (p = 0.02). For TG, MD = -4.99 (p = 0.000).
Conclusion: There exist a moderate to high quality of evidence in favor of the effects of aloe vera in patients with T2DM and pre-diabetes.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.dsx.2021.102292 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!